Similar articles

• [The metabolic effects of beta-receptor blockers. What is of practical importance in antihypertensive therapy?].

  Sawicki PT, Berger M. Sawicki PT, et al. Dtsch Med Wochenschr. 1992 May 29;117(22):875-9. doi: 10.1055/s-0029-1235345. Dtsch Med Wochenschr. 1992. PMID: 1350758 Review. German. No abstract available.
• [Beta-receptor blockers in hypertension: nonselective or selective].

  Fennis JF, van 't Laar A. Fennis JF, et al. Ned Tijdschr Geneeskd. 1978 Dec 9;122(49):1924-5. Ned Tijdschr Geneeskd. 1978. PMID: 31572 Dutch. No abstract available.
• [Beta receptor blockaders in the treatment of hypertension].

  Lohmöller G, Lydtin H. Lohmöller G, et al. Med Klin. 1976 Nov 19;71(47):2051-7. Med Klin. 1976. PMID: 12458 Review. German. No abstract available.
• Beta-adrenergic blocking agents in the treatment of hypertension. Choices based on pharmacological properties and patient characteristics.

  Wallin JD, Shah SV. Wallin JD, et al. Arch Intern Med. 1987 Apr;147(4):654-9. Arch Intern Med. 1987. PMID: 2881524 Review.
• beta-Blockers and hypertension: a therapeutic reappraisal.

  Panjrath GS, Sawhney S, Messerli FH. Panjrath GS, et al. Postgrad Med. 2005 Dec;118(6 Suppl Beta-Blockers):26-33. doi: 10.3810/pgm.12.2005.suppl43.229. Postgrad Med. 2005. PMID: 19667708